The first European consensus on vaccination in patients with multiple
Read moreMS and (Non-COVID) Vaccinations: Consensus Recommendations
Home »
Decreased COVID Antibody Response in MS Patients Taking Ocrelizumab
Editor’s note: Find the latest COVID-19 news and guidance in
Read moreSome MS Treatments May Heighten COVID Risk
Editor’s note: Find the latest COVID-19 news and guidance in
Read moreNatalizumab Postinfusion Reactions Rare; Is Monitoring Necessary?
Reactions to the infusion of natalizumab (Tysabri) for the treatment
Read more